Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study (Q46401872)
Jump to navigation
Jump to search
scientific article published in September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study |
scientific article published in September 2008 |
Statements
1 reference
Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study (English)
1 reference
John S Sundy
1 reference
Michael A Becker
1 reference
Herbert S B Baraf
1 reference
Andre Barkhuizen
1 reference
Larry W Moreland
1 reference
William Huang
1 reference
Royce W Waltrip
1 reference
Allan N Maroli
1 reference
Zeb Horowitz
1 reference
Pegloticase Phase 2 Study Investigators
1 reference
1 September 2008
1 reference
1 reference
58
1 reference
2882-2891
1 reference
9
1 reference
Identifiers
1 reference
1 reference